Has the Justice Department brought cases over illegal semaglutide or tirzepatide sales?
Has the Justice Department brought cases over illegal semaglutide or tirzepatide sales?
Yes. This index holds 1 Justice Department press release naming 1 firm or website over sales of semaglutide, tirzepatide or counterfeit GLP-1 products. This index read every press release on justice.gov’s press release list dated Jan 1, 2026 to Nov 14, 2026 (18,139 releases read through the department’s public press release API) and found 9 releases naming semaglutide, tirzepatide, another GLP-1 drug or a GLP-1 brand name. The other 8 name only individuals, so they are not listed as records.
An indictment, information, complaint or arrest is an allegation. Defendants are presumed innocent unless and until proven guilty in court.
| Release | |||||
|---|---|---|---|---|---|
| Jul 23, 2026 | U.S. Attorney’s Office, Western District of Michigan | Sentencing | MilestonePurity.com | Semaglutide, Tirzepatide | justice.gov |
What each release says
- U.S. Attorney’s Office, Western District of Michigan, Jul 23, 2026, “Gobles Man Sentenced for Selling Chinese Drugs Without FDA Approval”: “www.MilestonePurity.com. Both websites claimed that the drugs were “for research purposes only” even though Piper and his co-conspirators knew that customers would be using them personally.”
What was searched
This index read every press release on justice.gov’s press release list dated Jan 1, 2026 to Nov 14, 2026 (18,139 releases read through the department’s public press release API) and found 9 releases naming semaglutide, tirzepatide, another GLP-1 drug or a GLP-1 brand name.
The releases read but not listed, because they name only individuals: la-health-care-fraud-takedown-results-15-defendants-charged-including-six-medical, los-angeles-health-care-fraud-takedown-results-charges-against-15-defendants-including-6, two-indian-nationals-charged-connection-transnational-counterfeit-ozempic-scheme, two-indian-nationals-charged-connection-transnational-counterfeit-ozempic-scheme, illinois-man-charged-scheme-impersonate-doctors-and-make-false-statements-obtain-glp-1, 2026-national-health-care-fraud-takedown, utah-licensed-osteopathic-physician-indicted-allegedly-receiving-misbranded-drugs-china, chicago-nurse-charged-distributing-counterfeit-ozempic.
Common questions
What is the difference between an indictment, an information and a guilty plea?
An indictment is a charge returned by a grand jury and an information is a charge filed by a prosecutor; both are allegations. A guilty plea is a defendant’s admission in court to a charge, and a sentencing follows a plea or a conviction.
Does this cover the Federal Trade Commission?
No. The FTC website answered this index’s requests with an error page, so FTC cases and press releases were not read and nothing here describes them.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
- U.S. Department of Justice press releases (justice.gov press release API)
- U.S. Attorney’s Office, Western District of Michigan: Gobles Man Sentenced for Selling Chinese Drugs Without FDA Approval
Records last pulled Nov 15, 2026. Every entry links to the original public record.